A dot-com CDN just signed the largest contract in its history — 5x its cloud run-rate — to run agentic AI on CPUs. The re-rating is real, but the spike is not the entry.
The call: BUY Akamai (AKAM) on a pullback to $108–$118, target $165 base / $185 stretch, invalidation daily close below $98 — SPECULATIVE, 6–12 months.
Why now: $11.6B / 7-year Anthropic commitment (≈$1.66B ARR) + path to $20B transforms Cloud Infrastructure from $99M/quarter sidecar to the growth engine.
The disagreement: Consensus celebrates revenue; it underprices $5.5B capex, $1.7B memory pre-buy, and single-customer concentration into a 5.2% 10-year.
The level that changes everything: $111.33 — Anthropic's warrant strike. Hold above, the hypergrowth story sticks; lose $98, the financing math breaks.
Prices: AKAM $117.27 (+6.2% intraday Sep 25, high $129.57, prev close $110.41) · 10Y 5.17–5.19% (19-yr high) · S&P 500 7,704 · BTC $83,623 · Data via financial handler + Akamai 8-K/press release Sep 24, 2026. 中文版 → Chinese edition
Akamai signed $11.6B over 7 years to supply Anthropic with dedicated CPU cloud + managed services, with a contractual path to ~$20B. The 8-K (filed Sep 24, event Sep 18) makes this Projects 2 & 3 under a Master Services Agreement dated May 5, 2026 — i.e., this relationship scaled 20x in four months.
Read the Akamai press release (Sep 24, 2026) and the 8-K Item 1.01 together, because the press release omits what the filing discloses:
Consequence: this is not incremental bookings. With $14.6B in CIS commitments signed YTD (vs. $2.8B disclosed at Q2), Akamai just pre-sold ~3 years of its current total company revenue ($4.45–$4.53B guide) in one vertical.
Before the deal, Akamai was 55% security, 36% declining delivery, 9% hypergrowth cloud. Q2 2026 (reported Aug 6) tells the story: total $1.10B +5% YoY, Security $604M +10%, Delivery $396M –6%, CIS $99M +39% YoY, GAAP op margin collapsed to 7% (–8pts) and non-GAAP to 25% (–5pts) on cloud build.
Full-year guide was pedestrian: $4.445–$4.530B (+6–8%), non-GAAP EPS $6.40–$7.05, op margin 25–26%. At $110 pre-deal, AKAM traded ~15.5x 2026 non-GAAP EPS midpoint — a value multiple for 5.9% trailing revenue growth, 40.2x trailing GAAP P/E, ROE 8.5%. The 52-week range ($70.82–$165.45) shows how violently the market has swung between “CDN in decline” and “edge-AI option.”
My opinion: the bear case was never wrong on delivery — it was early on obsolescence. Delivery still shrinks mid-single digits, but security (10% growth, 57.5% gross margin company-wide) pays the bills while CIS scales. The Anthropic deal does not fix delivery; it makes delivery irrelevant — if executed. Piper Sandler’s line is exactly right: CIS overtakes Security by late 2028 at this pace, flipping AKAM from value to hypergrowth.
Anthropic chose distributed CPUs, not GPUs, for agentic inference — and that validates a second AI hardware stack. Per CNBC’s roundup of Wall Street notes, Oppenheimer sizes the deal at ~77MW at ~$22M annual revenue/MW (~$1.7B run-rate). CPUs handle coordinated, low-latency, memory-heavy agent tasks (voice agents, robotics, real-time video, world simulation — all named by DA Davidson from Akamai’s call) better and cheaper than GPU clusters.
BofA’s instant reaction — hiking AMD’s target to $720 because the deal “further supports CPU importance in the agentic era” — is the tell. My read, as opinion: NVIDIA trains, AMD + Intel + Akamai’s edge serve. Akamai’s 4,000+ PoPs (core-to-edge continuum) let Anthropic run inference near users/agents without building new mega-campuses — critical when Oracle just declared force majeure on a data-center build and Blue Owl’s Project Jupiter slipped a year on power constraints.
Downstream consequences that matter for your portfolio:
At full run-rate, the Anthropic base deal alone is worth roughly $4–$5 of EPS — doubling Akamai’s earnings power. Here is the checkable arithmetic (see Appendix B for assumptions):
Capex intensity is the load-bearing assumption: $5.5B / $11.6B = 47% capex-to-contract, or ~$70M/MW (Oppenheimer). That is financeable — Akamai held $4.62B cash/securities at Jun 30 and generates ~30% OCF margin ($326M in Q2) — but it front-loads spend into a 5.2% yield curve. Every 100bps on $3B of incremental debt is ~$30M pre-tax, or ~$0.16/share. In 2022 parallel conditions (BofA’s warning today), that math killed unprofitable growth. Akamai is profitable, but free cash flow goes negative in 2026–27 before inflecting in 2028.
My judgment: fair value $165 base (15x 2028 $11), $185 bull (expanded $20B at 70% probability-adjusted), $95 bear (execution slip + customer concentration discount). Do not pay $129 for it today — the stock tagged $129.57 intraday (+17%) then faded to $117 as rates re-spiked. The warrant strike $111.33 is your gravitational center.
One customer, one architecture, one memory cycle — funded at 19-year-high rates.
Chasing +17% into a bond selloff is how you turn a great contract into a bad trade. Wait for the rate-driven fade; Akamai always fades day-1 AI spikes (it did after the $600M robotics deal in August).
| Field | Level |
|---|---|
| Action / Entry | BUY $108–$118 (scale: 1/3 at $117, 2/3 on dip to $110 / $108). No chase above $128. |
| Target | $165 base (MS/Piper zone, +41% from $117); stretch $185 (DA Davidson, full $20B path) |
| Invalidation | Daily close below $98 (loses pre-deal breakout + 30-day VWAP; thesis breaks, not wobbles) |
| Timeframe | 6–12 months for repricing; 2027 revenue ($150–$300M) is first proof point |
| Conviction | SPECULATIVE (one massive signal, unconfirmed execution; size 1–2% starter, add on Lenovo/Jabil delivery milestones) |
| Audience | Diversifiers beyond mega-cap AI; not for duration-sensitive income holders at 5%+ yields |
Bull–base–bear (probability-weighted, 12-month):
I am wrong if Akamai cannot convert watts to dollars. Specifically: (1) Q4 2026 or Q1 2027 CIS revenue fails to accelerate past $130M/quarter (implies <$150M 2027 Anthropic contribution tracking); (2) capex ex-memory exceeds $3.8B residual without MW disclosure; (3) Anthropic does not make first Project 3 payment (warrant 40% fails to vest) by Q1 2027; (4) daily close below $98. Any one triggers exit, no second chances.
Catalyst calendar: Micron earnings Sep 30 (memory pricing read-through); PCE + JOLTS next week (rate path for funding); Akamai Q3 print early November (watch CIS guide ex-Anthropic); Lenovo/Jabil delivery milestones in Q4 10-Q exhibit filing (the full MSA text lands with Sep 30 10-Q).
Positioning note vs. open book: this complements EQ-ORCL-1 (fade Oracle on force-majeure/build risk) — Akamai is the distributed, asset-light mirror to Oracle’s centralized mega-build. It does not conflict with MACRO-5PCT-1 (fade duration above 5.10%); if 10Y breaks sustainably below 5.05%, add to AKAM — cheaper funding steepens skew to bull.
Base EPS build: ($1.657B × 30% EBIT = $497M; × (1–19%) = $403M / 150M shares = $2.68) + $7.70 standalone 2028 = ~$10.38 → 15x = $156, rounded to $165 on growth premium. Bull adds $9B × 30% × 81% / 150M = +$3.65 → ~$14.0 × 15x = $210. Bear: margin 18% + no expansion + multiple 12x on $8 = $96.
Load-bearing: 30% EBIT at full run-rate (DA Davidson). If true opex + power + depreciation drag it to 18%, base EPS falls to ~$9.0 and fair value to ~$135 — still above entry but 18% below target. Watch non-GAAP op margin quarterly: must trough in H2 2026 and expand from Q2 2027.